Cargando…
Publisher Correction: Discovery of targetable genetic alterations in advanced non-small cell lung cancer using a next-generation sequencing-based circulating tumor DNA assay
Autores principales: | Hou, Helei, Yang, Xiaonan, Zhang, Jinping, Zhang, Zhe, Xu, Xiaomei, Zhang, Xiaoping, Zhang, Chuantao, Liu, Dong, Yan, Weihua, Zhou, Na, Zhu, Hongmei, Qian, Zhaoyang, Li, Zhuokun, Zhang, Xiaochun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768795/ https://www.ncbi.nlm.nih.gov/pubmed/29335459 http://dx.doi.org/10.1038/s41598-018-19648-9 |
Ejemplares similares
-
Discovery of targetable genetic alterations in advanced non-small cell lung cancer using a next-generation sequencing-based circulating tumor DNA assay
por: Hou, Helei, et al.
Publicado: (2017) -
Targeted next generation sequencing in Chinese colorectal cancer patients guided anti-EGFR treatment and facilitated precision cancer medicine
por: Hou, Helei, et al.
Publicado: (2017) -
KIT/PDGFRA/KDR amplification defines a novel molecular subtype of adenoid cystic carcinoma patients who may benefit from treatment with tyrosine kinase inhibitors
por: Hou, Helei, et al.
Publicado: (2020) -
The efficacy and safety of apatinib for refractory malignancies: a review and meta-analysis
por: Sun, Dantong, et al.
Publicado: (2018) -
Publisher Correction: Accelerating functional gene discovery in osteoarthritis
por: Butterfield, Natalie C., et al.
Publicado: (2021)